Macrophage activation syndrome and etanercept in children with systemic juvenile rheumatoid arthritis

J Rheumatol. 2004 Mar;31(3):623; author reply 623-4.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / immunology
  • Arthritis, Juvenile / complications*
  • Child
  • Epstein-Barr Virus Infections / complications*
  • Epstein-Barr Virus Infections / immunology
  • Etanercept
  • Female
  • Humans
  • Immune System Diseases / etiology*
  • Immune System Diseases / immunology
  • Immunoglobulin G / adverse effects*
  • Immunoglobulin G / immunology
  • Macrophage Activation / immunology*
  • Receptors, Tumor Necrosis Factor / immunology
  • Syndrome

Substances

  • Antirheumatic Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Etanercept